Replies to post #221536 on Biotech Values

[dewophile]

It seems the Bavencio + axitinib data in 1L RCC is adding fuel to the fire for BMY

[DewDiligence]

~15% of US 1L-NSCLC patients are getting TBM measured, according to BMY’s #Q18 CC (just ended).